Abstract
Postictal agitation is a frequent complication during the emergence period after ECT. This symptom commonly resolves naturally within 1 h, but a severe or persistent episode requires pharmacological treatment with benzodiazepines or propofol to control the acute situation. Hypoxemia following ECT can also occur in this period, and monitoring of oxygen saturation should be continued until psychomotor function resumes. When desaturation is prolonged, initial pulmonary aspiration of increased saliva or gastric contents is suggested. Patients generally require about 2 h of post-ECT care in the recovery room and adverse symptoms, especially headache, should be noted. Elderly patients have a high risk of fall and should be monitored carefully. Memory disturbance is an important cognitive impairment during and after ECT course and may impair optimal functioning. In some cases, ECT parameters should be modified based on the assessment of cognitive function to minimize this adverse effect. Continuation/maintenance ECT is an effective treatment option for relapse prevention after successful treatment with index ECT and is often performed in an ambulatory setting. The decision to transfer the patient from inpatient to ambulatory ECT requires careful assessment of the treatment response and adverse effects of ECT.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mankad MV, Weiner RD. Adverse effects. In: Mankad MV, Beyer JL, Weiner RD, Krystal AD, editors. Clinical manual of electroconvulsive therapy. Arlington: American Psychiatric Publishing, Inc.; 2010. p. 139–48.
Auriacombe M, Rénéric JP, Usandizaga D, Gomez F, Combourieu I, Tignol J. Post-ECT agitation and plasma lactate concentrations. J ECT. 2000;16:263–7.
Cristancho MA, Alici Y, Augoustides JG, O’Reardon JP. Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician. Curr Psychiatry Rep. 2008;10:474–80.
Kikuchi A, Yasui-Furukori N, Fujii A, Katagai H, Kaneko S. Identification of predictors of post-ictal delirium after electroconvulsive therapy. Psychiatry Clin Neurosci. 2009;63:180–5.
Sato M, Hirota K, Shirakami G, Kakuyama M, Tanabe H, Fukuda K. Safety in general anesthesia for ambulatory electroconvulsive therapy. Masui. 2013;62:52–9.
Mankad MV, Weiner RD. Anesthetics and other medications. In: Mankad MV, Beyer JL, Weiner RD, Krystal AD, editors. Clinical manual of electroconvulsive therapy. Arlington: American Psychiatric Publishing, Inc.; 2010. p. 81–93.
Augoustides JG, Greenblatt E, Abbas MA, O'Reardon JP, Datto CJ. Clinical approach to agitation after electroconvulsive therapy: a case report and literature review. J ECT. 2002;18:213–7.
O'Reardon JP, Takieddine N, Datto CJ, Augoustides JG. Propofol for the management of emergence agitation after electroconvulsive therapy: review of a case series. J ECT. 2006;22:247–52.
Tzabazis A, Schmitt HJ, Ihmsen H, Schmidtlein M, Zimmermann R, Wielopolski J, et al. Postictal agitation after electroconvulsive therapy: incidence, severity, and propofol as a treatment option. J ECT. 2013;29:189–95.
Mizrak A, Koruk S, Ganidagli S, Bulut M, Oner U. Premedication with dexmedetomidine and midazolam attenuates agitation after electroconvulsive therapy. J Anesth. 2009;23:6–10.
O’Brien EM, Rosenquist PB, Kimball JN, Dunn GN, Smith B, Arias LM. Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation: a case report. J ECT. 2010;26:131–3.
Bryson EO, Briggs MC, Pasculli RM, Kellner CH. Treatment-resistant postictal agitation after electroconvulsive therapy (ECT) controlled with dexmedetomidine. J ECT. 2013;29, e18.
Vishne T, Amiaz R, Grunhaus L. Promethazine for the treatment of agitation after electroconvulsive therapy: a case series. J ECT. 2005;21:118–21.
Small JG, Milstein V. Lithium interactions: lithium and electroconvulsive therapy. J Clin Psychopharmacol. 1990;10:346–50.
Prudic J. Strategies to minimize cognitive side effects with ECT: aspects of ECT technique. J ECT. 2008;24:46–51.
Swartz CM. Electroconvulsive therapy emergence agitation and succinylcholine dose. J Nerv Ment Dis. 1990;178:455–7.
Devanand DP, Sackeim HA. Use of increased anesthetic dose prior to electroconvulsive therapy to prevent postictal excitement. Gen Hosp Psychiatry. 1992;14:345–9.
Reti IM, Krishnan A, Podlisky A, Sharp A, Walker M, Neufeld KJ, et al. Predictors of electroconvulsive therapy postictal delirium. Psychosomatics. 2014;55:272–9.
American Psychiatric Association Committee on Electroconvulsive Therapy. The practice of electroconvulsive therapy: Recommendations for treatment, training, and privileging. 2nd ed. Washington, DC: American Psychiatric Association; 2001.
Bailine SH, Petrides G, Doft M, Lui G. Indications for the use of propofol in electroconvulsive therapy. J ECT. 2003;19:129–32.
Krystal AD. Managing the ECT seizure. In: Mankad MV, Beyer JL, Weiner RD, Krystal AD, editors. Clinical manual of electroconvulsive therapy. Arlington: American Psychiatric Publishing, Inc.; 2010. p. 149–57.
Avramov MN, Husain MM, White PF. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg. 1995;81:596–602.
Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med. 1998;338:970–6.
Saito S. Anesthesia management for electroconvulsive therapy: hemodynamic and respiratory management. J Anesth. 2005;19:142–9.
Saito S, Kadoi Y, Nihishara F, Aso C, Goto F. End-tidal carbon dioxide monitoring stabilized hemodynamic changes during ECT. J ECT. 2003;19:26–30.
Mayur PM, Shree RS, Gangadhar BN, Subbakrishna DK, Janakiramaiah N, Rao GS. Atropine premedication and the cardiovascular response to electroconvulsive therapy. Br J Anaesth. 1998;81:466–7.
Ding Z, White PF. Anesthesia for electroconvulsive therapy. Anesth Analg. 2002;94:1351–64.
Tecoult E, Nathan N. Morbidity in electroconvulsive therapy. Eur J Anaesthesiol. 2001;18:511–8.
McCormick AS, Saunders DA. Oxygen saturation of patients recovering from electroconvulsive therapy. Anaesthesia. 1996;51:702–4.
Wayne SL, O'Donovan CA, McCall WV, Link K. Postictal neurogenic pulmonary edema: experience from an ECT model. Convuls Ther. 1997;13:181–4.
Kurnutala LN, Kamath S, Koyfman S, Yarmush J, SchianodiCola J. Aspiration during electroconvulsive therapy under general anesthesia. J ECT. 2013;29, e68.
Burke WJ, Rubin EH, Zorumski CF, Wetzel RD. The safety of ECT in geriatric psychiatry. J Am Geriatr Soc. 1987;35:516–21.
Buisseret P. Acute pulmonary edema following grand mal epilepsy and as a complication of electric shock therapy. Br J Dis Chest. 1982;76:194–5.
Takahashi T, Kinoshita K, Fuke T, Urushihata K, Kawamata T, Yanagisawa S, et al. Acute neurogenic pulmonary edema following electroconvulsive therapy: a case report. Gen Hosp Psychiatry. 2012;34:703.e9–703.e11.
Myers CL, Gopalka A, Glick D, Goldman MB, Dinwiddie SH. A case of negative-pressure pulmonary edema after electroconvulsive therapy. J ECT 2007;23:281–3.
Cochran M, DeBattista C, Schmiesing C, Brock-Utne JG. Negative-pressure pulmonary edema: a potential hazard in patients undergoing ECT. J ECT. 1999;15:168–70.
Weber DL, Ruvolo C, Cashin P. Sudden death following electroconvulsive therapy. N Y State J Med. 1973;73:1000–1.
Mamah D, Lammle M, Isenberg KE. Pulmonary embolism after ECT. J ECT. 2005;21:39–40.
Singh G, Wahi S. Pulmonary embolism in the ECT patient: a case report and discussion. Gen Hosp Psychiatry. 2008;30:87–9.
Mehta V, Mueller PS, Gonzalez-Arriaza HL, Pankratz VS, Rummans TA. Safety of electroconvulsive therapy in patients receiving long-term warfarin therapy. Mayo Clin Proc. 2004;79:1396–401.
Saito S, Kadoi Y, Iriuchijima N, Obata H, Arai K, Morita T, et al. Reduction of cerebral hyperemia with anti-hypertensive medication after electroconvulsive therapy. Can J Anaesth. 2000;47:767–74.
Sundsted KK, Burton MC, Shah R, Lapid MI. Preanesthesia medical evaluation for electroconvulsive therapy: a review of the literature. J ECT. 2014;30:35–42.
MacPherson RD, Loo CK. Cognitive impairment following electroconvulsive therapy – does the choice of anesthetic agent make a difference? J ECT. 2008;24:52–6.
Hooten WM, Rasmussen KG. Effects of general anesthetic agents in adults receiving electroconvulsive therapy: a systematic review. J ECT. 2008;24:208–23.
Rasmussen KG. Propofol for ECT anesthesia a review of the literature. J ECT. 2014;30:210–5.
Irvin SM. Treatment of depression with outpatient electroconvulsive therapy. AORN J. 1997;65:573–82.
Li TC, Shiah IS, Sun CJ, Tzang RF, Huang KC, Lee WK. Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature. J ECT. 2011;27:165–7.
Markowitz JS, Kellner CH, DeVane CL, Beale MD, Folk J, Burns C, et al. Intranasal sumatriptan in post-ECT headache: results of an open-label trial. J ECT. 2001;17:280–3.
Weiner SJ, Ward TN, Ravaris CL. Headache and electroconvulsive therapy. Headache. 1994;34:155–9.
Leung M, Hollander Y, Brown GR. Pretreatment with ibuprofen to prevent electroconvulsive therapy-induced headache. J Clin Psychiatry. 2003;64:551–3.
White PF, Purdue L, Downing M, Thornton L. Intranasal sumatriptan for prevention of post-ECT headaches. Headache. 2006;46:692.
Kramer BA, Kadar AG, Clark K. Use of the Neuro-Wrap system for severe post-electroconvulsive therapy headaches. J ECT. 2008;24:152–5.
Kramer BA, Kadar AG, Clark K. Transcutaneous acupoint electrical stimulation in preventing and treating nausea and vomiting in patients receiving electroconvulsive therapy. J ECT. 2003;19:194–6.
Cattan RA, Barry PP, Mead G, Reefe WE, Gay A, Silverman M. Electroconvulsive therapy in octogenarians. J Am Geriatr Soc. 1990;38:753–8.
van der Wurff FB, Stek ML, Hoogendijk WJ, Beekman AT. The efficacy and safety of ECT in depressed older adults: a literature review. Int J Geriatr Psychiatry. 2003;18:894–904.
de Carle AJ, Kohn R. Electroconvulsive therapy and falls in the elderly. J ECT. 2000;16:252–7.
Reti IM, Walker M, Pulia K, Gallegos J, Jayaram G, Vaidya P. Safety considerations for outpatient electroconvulsive therapy. J Psychiatr Pract. 2012;18:130–6.
Fink M, Abrams R, Bailine S, Jaffe R. Ambulatory electroconvulsive therapy: report of a task force of the association for convulsive therapy. Convuls Ther. 1996;12:42–55.
Awad IT, Chung F. Factors affecting recovery and discharge following ambulatory surgery. Can J Anaesth. 2006;53:858–72.
Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry. 2010;68:568–77.
Verwijk E, Comijs HC, Kok RM, Spaans HP, Stek ML, Scherder EJ. Neurocognitive effects after brief pulse and ultrabrief pulse unilateral electroconvulsive therapy for major depression: a review. J Affect Disord. 2012;140:233–43.
Meeter M, Murre JM, Janssen SM, Birkenhager T, van den Broek WW. Retrograde amnesia after electroconvulsive therapy: a temporary effect? J Affect Disord. 2011;132:216–22.
Herrmann LL, Goodwin GM, Ebmeier KP. The cognitive neuropsychology of depression in the elderly. Psychol Med. 2007;37:1693–702.
Porter RJ, Douglas K, Knight RG. Monitoring of cognitive effects during a course of electroconvulsive therapy: recommendations for clinical practice. J ECT. 2008;24:25–34.
Geretsegger C, Nickel M, Judendorfer B, Rochowanski E, Novak E, Aichhorn W. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. J ECT. 2007;23:239–43.
Vaidya PV, Anderson EL, Bobb A, Pulia K, Jayaram G, Reti I. A within-subject comparison of propofol and methohexital anesthesia for electroconvulsive therapy. J ECT. 2012;28:14–9.
Bauer J, Hageman I, Dam H, Báez A, Bolwig T, Roed J, et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. J ECT. 2009;25:85–90.
Ingram A, Schweitzer I, Ng CH, Saling MM, Savage G. A comparison of propofol and thiopentone use in electroconvulsive therapy: cognitive and efficacy effects. J ECT. 2007;23:158–62.
Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 2007;32:244–54.
Fazzino TL, Rabinowitz T, Althoff RR, Helzer JE. Monitoring daily affective symptoms and memory function using interactive voice response in outpatients receiving electroconvulsive therapy. J ECT. 2013;29:318–24.
Jaffe R, Dubin W, Shoyer B, Roemer R, Sharon D, Lipschutz L. Outpatient electroconvulsive therapy: efficacy and safety. Convuls Ther. 1990;6:231–8.
Dew R, McCall WV. Efficiency of outpatient ECT. J ECT. 2004;20:24–5.
Trevino K, McClintock SM, Husain MM. A review of continuation electroconvulsive therapy: application, safety, and efficacy. J ECT. 2010;26:186–95.
Petrides G, Tobias KG, Kellner CH, Rudorfer MV. Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature. Neuropsychobiology. 2011;64:129–40.
van Schaik AM, Comijs HC, Sonnenberg CM, Beekman AT, Sienaert P, Stek ML. Efficacy and safety of continuation and maintenance electroconvulsive therapy in depressed elderly patients: a systematic review. Am J Geriatr Psychiatry. 2012;20:5–17.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Japan
About this chapter
Cite this chapter
Sato, M. (2016). Postprocedural Assessments and Considerations. In: Saito, S. (eds) Anesthesia Management for Electroconvulsive Therapy. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55717-3_6
Download citation
DOI: https://doi.org/10.1007/978-4-431-55717-3_6
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55716-6
Online ISBN: 978-4-431-55717-3
eBook Packages: MedicineMedicine (R0)